TIAA CREF Investment Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $1.65M | Sell |
6,795
-201
| -3% | -$48.9K | ﹤0.01% | 2093 |
|
2018
Q4 | $1.33M | Sell |
6,996
-184
| -3% | -$35.1K | ﹤0.01% | 2169 |
|
2018
Q3 | $2.36M | Sell |
7,180
-217
| -3% | -$71.2K | ﹤0.01% | 2042 |
|
2018
Q2 | $2.31M | Sell |
7,397
-522
| -7% | -$163K | ﹤0.01% | 2096 |
|
2018
Q1 | $1.93M | Buy |
7,919
+42
| +0.5% | +$10.2K | ﹤0.01% | 2127 |
|
2017
Q4 | $2.38M | Sell |
7,877
-321
| -4% | -$96.9K | ﹤0.01% | 2035 |
|
2017
Q3 | $2.17M | Sell |
8,198
-226
| -3% | -$59.8K | ﹤0.01% | 2122 |
|
2017
Q2 | $2.22M | Buy |
8,424
+604
| +8% | +$159K | ﹤0.01% | 2116 |
|
2017
Q1 | $2.82M | Sell |
7,820
-659
| -8% | -$237K | ﹤0.01% | 1932 |
|
2016
Q4 | $2.45M | Sell |
8,479
-452
| -5% | -$130K | ﹤0.01% | 2068 |
|
2016
Q3 | $3.04K | Sell |
8,931
-27
| -0.3% | -$9 | ﹤0.01% | 1921 |
|
2016
Q2 | $3.81M | Buy |
8,958
+220
| +3% | +$93.5K | ﹤0.01% | 1736 |
|
2016
Q1 | $2.8M | Buy |
8,738
+512
| +6% | +$164K | ﹤0.01% | 1898 |
|
2015
Q4 | $4.27M | Sell |
8,226
-146
| -2% | -$75.7K | ﹤0.01% | 1666 |
|
2015
Q3 | $2.45M | Sell |
8,372
-333
| -4% | -$97.6K | ﹤0.01% | 2022 |
|
2015
Q2 | $3.42M | Buy |
8,705
+759
| +10% | +$298K | ﹤0.01% | 1950 |
|
2015
Q1 | $2.4M | Buy |
7,946
+467
| +6% | +$141K | ﹤0.01% | 2122 |
|
2014
Q4 | $1.66M | Sell |
7,479
-46
| -0.6% | -$10.2K | ﹤0.01% | 2360 |
|
2014
Q3 | $1.75M | Sell |
7,525
-199
| -3% | -$46.2K | ﹤0.01% | 2312 |
|
2014
Q2 | $1.71M | Buy |
7,724
+792
| +11% | +$175K | ﹤0.01% | 2400 |
|
2014
Q1 | $2.19M | Sell |
6,932
-127
| -2% | -$40.1K | ﹤0.01% | 2192 |
|
2013
Q4 | $1.84M | Buy |
7,059
+674
| +11% | +$176K | ﹤0.01% | 2305 |
|
2013
Q3 | $935K | Buy |
6,385
+47
| +0.7% | +$6.88K | ﹤0.01% | 2645 |
|
2013
Q2 | $960K | Buy |
+6,338
| New | +$960K | ﹤0.01% | 2608 |
|